Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts

Hepatology

Volumn 34, Issue 5, 2001, Pages 943-952

  Fehrenbach, Heinz ^a   Weiskirchen, Ralf ^b   Kasper, Michael ^c   Gressner, Axel M ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA ACTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SPECIFICITY; CELL SPREADING; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FIBROGENESIS; GENE CONTROL; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE TEST; IMMUNOGOLD STAINING; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CULTURE; LIVER REGENERATION; LIVER RESECTION; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STELLATE CELL; WESTERN BLOTTING;

EID: 0034768777     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.28788     Document Type: Article

References (58)

1. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins
2. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions
3. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs
4. Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
5. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues
6. The biology of the receptor for advanced glycation end products and its ligands
7. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease
8. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
9. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor κB (NF-κB) activation
10. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus
11. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells
12. The role of oxidative stress and NF-kappaB activation in late diabetic complications
13. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and coexpression of rage and amphoterin in the developing nervous system
14. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways
15. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation
16. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
17. Blockade of receptor for AGE (RAGE): A novel strategy results in enhanced regeneration and marked survival benefit after massive hepatectomy in mice
18. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: A key event in hepatic fibrogenesis
19. Pathobiology of hepatic stellate cells
20. The virtuosity of hepatic stellate cells
21. New aspects of hepatic fibrosis
22. The cell biology of liver fibrogenesis - An imbalance of proliferation, growth arrest and apoptosis of myofibroblasts
23. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
24. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand
25. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells
26. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts
27. Sequencing of two alternatively spliced mRNAs corresponding to the extracellular domain of the rat receptor for advanced glycosylation end products (RAGE)
28. Preparation of isolated rat liver cells
29. Purified rat liver fat-storing cells in culture divide and contain collagen
30. The synthesis of proteoglycans in fat-storing cells of rat liver
31. Kupffer cell-mediated induction of synthesis and secretion of proteoglycans by rat liver fat-storing cells in culture
32. Isolation and characterization of Kupffer and endothelial cells from the rat liver
33. Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver
34. The cysteine- and glycine-rich LIM domain protein CRP2 specifically interacts with a novel human protein (CRP2BP)
35. Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats
36. The human and rat recombinant receptors for advanced glycation end products have a high degree of homology but different pharmacokinetic properties in rats
37. Receptor for advanced glycation end products (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung
38. Immunohistochemical investigations on the differentiation marker protein E11 in rat calvaria, calvaria cell culture and the osteoblastic cell line ROS 17/2.8
39. Immunohistochemical evidence for loss of ICAM-1 by alveolar epithelial cells in pulmonary fibrosis
40. Sequence and expression of a glyceraldehyde-3 -phosphate dehydrogenase-encoding gene from quail embryo fibroblasts
41. Prostacyclin administration suppresses the increase in hepatic levels of COL1A(I) and glyceraldehyde-3 -phosphate dehydrogenase mRNAs in the rat treated with carbon tetrachloride
42. Multiple insulin-responsive elements regulate transcription of the GAPDH gene
43. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
44. Role of galactin-3 as a receptor for advanced glycosylation end products
45. Two novel rat liver membrane proteins that bind advanced glycosylation end products: Relationship to macrophage receptor for glucose-modified proteins
46. Molecular identity and cellular distribution of advanced glycation end product receptors: Relationship of p60 to OST-48 and p90 to 80K-H membrane proteins
47. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells
48. Hepatic advanced glycation endproduct binding is increased in experimental diabetes
49. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
50. Elevated serum levels of astroglial S100beta in patients with liver cirrhosis indicate early and subclinical portal-systemic encephalopathy
51. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation
52. Connective tissue growth factor (CTGF) is upregulated after high glucose in the liver. Relevance for the pathogenesis of fibrosis development in non-alcoholic steatohepatitis (NASH)
53. Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: A potential mechanism for expansion of extracellular matrix in diabetes mellitus
54. Expression of connective tissue growth factor in experimental rat and human liver fibrosis
55. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells
56. Transforming growth factor-betal induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells
57. Role of Ras and Mapks in TGFbeta signaling